WATSON LABS INC FDA Approval ANDA 209406

ANDA 209406

WATSON LABS INC

FDA Drug Application

Application #209406

Documents

Letter2021-01-07

Application Sponsors

ANDA 209406WATSON LABS INC

Marketing Status

Prescription001

Application Products

001SUSPENSION/DROPS;OPHTHALMIC1%0BRINZOLAMIDEBRINZOLAMIDE

FDA Submissions

UNKNOWN; ORIG1AP2020-11-27STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB

CDER Filings

WATSON LABS INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 209406
            [companyName] => WATSON LABS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"BRINZOLAMIDE","activeIngredients":"BRINZOLAMIDE","strength":"1%","dosageForm":"SUSPENSION\/DROPS;OPHTHALMIC","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"11\/27\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-11-27
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.